The @injective Summit in Washington. + $INJ just landed on Robinhood. + Injective has filed for transfer agent registration with the SEC. AND here is why we believe $INJ is one of the best reward-to-risk buys of the summer. 👇 ✦ FUNDAMENTALS Injective is a purpose-built L1 for finance, not a general chain chasing every use case. Sub-0.6s blocks, 25k+ TPS, and a MultiVM design (native EVM live since November) built for order books, perps, and tokenized assets. ✦ TOKENOMICS Supply is fully circulating at 100M INJ. No unlock cliffs, no future dilution waiting to dump. 60% of exchange fees route into on-chain buyback-and-burn auctions. Over 7.1M INJ (~$36.6M) already burned, and IIP-617 doubled the burn rate. Native USDC via Circle's CCTP, so settlement runs on real dollars, not wrapped-token risk. INJ is the gas, the stake securing the chain, the governance vote, and the fee sink. Usage and scarcity are linked by design. A shrinking float against rising usage is the cleanest version of a supply story in this market. That's just positive signal over positive signal when it comes to the tokenomics. ✦ PROGRESS The catalysts are not promises anymore. They are landing: → Robinhood listing (July 16). Millions of US retail users can now buy INJ without a crypto-native wallet. The distribution problem is solved. → SEC transfer agent registration (July 16). A regulated path to issue and record securities ownership on-chain, not just wrap them. → x402 Foundation core member (July 15), seated next to Google, AWS, Visa, Mastercard, Stripe, Coinbase, and Circle to build the payment standard for AI agents. → Canary's Staked INJ ETF (ticker INJS, Cboe BZX, BitGo custody) sitting in the SEC pipeline. → CFTC-regulated INJ futures live on Bitnomial since April, plus a regulated M-INJ fund in Thailand. → The Injective Policy Institute now working policy from inside Washington. No other mid-cap L1 is stacking retail access, regulated derivatives, an ETF filing, and a securities-issuance pathway at the same time. ✦ PRICE ACTION AND POTENTIAL Here is the divergence. All of that, and INJ trades around $5, roughly 90% below its $52.62 all-time high, near the edge of the top 100 at a ~$490M cap. From my personal POV (and not financial advice), this is an opportunity - a massive one. We've already seen the fundamentals, tokenomics and 2026 progress. I don't believe $INJ is a ~500M MC token. Not at all. For me, its in the league above it. The chart is starting to turn: Just reclaimed the 30-day SMA (~$4.85) and the 50% Fib retracement (~$5.06) on volume up ~26% to ~$86.9M. First resistance sits near $5.30, then the $5.50 to $6 zone, with $7 as the level that confirms a real trend shift. Support holds in the $4.60 to $4.80 band. The reward-to-risk math is what stands out. Downside is cushioned by a fully circulating supply, an active burn, and a defined support zone near cycle lows. Upside is tied to conversion: ETF approval, securities actually settling on-chain, agentic payments routing real volume. When the groundwork sits this far ahead of a ~$490M cap, the gap tends to close on the catalysts, not the other way around. The risk is real too. Filings are not approvals. Summits invite sell-the-news. And INJ still moves with the broader market. This is a high-conviction setup, not a guarantee. But if you are hunting asymmetry this summer, a fully-built finance chain trading near the bottom of its range while the regulated on-ramps switch on one by one is about as clean as it gets. Not financial advice. Watch what settles, not what gets filed.